| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047759092 |
| P356 | DOI | 10.1038/NATURE06166 |
| P3181 | OpenCitations bibliographic resource ID | 2485549 |
| P698 | PubMed publication ID | 17898714 |
| P5875 | ResearchGate publication ID | 5945448 |
| P50 | author | Bernhard Lüscher | Q38325972 |
| Henning Kleine | Q43266970 | ||
| Bruno Amati | Q43817846 | ||
| P2093 | author name string | Fabio Casadio | |
| Ernesto Guccione | |||
| Francesca Martinato | |||
| Matteo Cesaroni | |||
| Christian Bassi | |||
| Henning Schuchlautz | |||
| P2860 | cites work | Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1 | Q24291436 |
| Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1 | Q24299067 | ||
| Structural basis for molecular recognition and presentation of histone H3 by WDR5 | Q24301311 | ||
| Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus | Q24313196 | ||
| Structural basis for the specific recognition of methylated histone H3 lysine 4 by the WD-40 protein WDR5 | Q24314963 | ||
| Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II | Q24337471 | ||
| Methylation at arginine 17 of histone H3 is linked to gene activation | Q24522543 | ||
| Histone modifications defining active genes persist after transcriptional and mitotic inactivation | Q24557457 | ||
| Histone arginine methylation regulates pluripotency in the early mouse embryo | Q24620580 | ||
| Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region | Q24672150 | ||
| The role of chromatin during transcription | Q27860995 | ||
| Chromatin modifications and their function | Q27861067 | ||
| A generic protein purification method for protein complex characterization and proteome exploration | Q27861087 | ||
| Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression | Q28512283 | ||
| Methylation of histone H3 by coactivator-associated arginine methyltransferase 1 | Q28589913 | ||
| The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains | Q29614228 | ||
| Genomic maps and comparative analysis of histone modifications in human and mouse | Q29614418 | ||
| Regulation of MLL1 H3K4 methyltransferase activity by its core components | Q29614518 | ||
| WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development | Q29614526 | ||
| Arginine methylation an emerging regulator of protein function | Q29617311 | ||
| Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications | Q33917698 | ||
| Crosstalk between CARM1 methylation and CBP acetylation on histone H3. | Q33963308 | ||
| Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex | Q34546055 | ||
| Molecular recognition of histone H3 by the WD40 protein WDR5. | Q34546063 | ||
| Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes | Q34554800 | ||
| Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation | Q34694111 | ||
| Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation | Q35131664 | ||
| A COMPASS in the voyage of defining the role of trithorax/MLL-containing complexes: linking leukemogensis to covalent modifications of chromatin | Q36078193 | ||
| Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential | Q36605563 | ||
| Histone H3 Lys 4 methylation: caught in a bind? | Q36624324 | ||
| Myc-binding-site recognition in the human genome is determined by chromatin context | Q38312447 | ||
| Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. | Q40424280 | ||
| Cell cycle activation by c-myc in a burkitt lymphoma model cell line. | Q40859219 | ||
| P433 | issue | 7164 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Coactivator associated arginine methyltransferase 1 | Q5008826 |
| histone methyltransferase activity (H4-R3 specific) | Q21131673 | ||
| histone methyltransferase activity (H3-R2 specific) | Q21131674 | ||
| histone methyltransferase activity (H2A-R3 specific) | Q21131676 | ||
| Protein arginine methyltransferase 6 | Q21131677 | ||
| P304 | page(s) | 933-937 | |
| P577 | publication date | 2007-09-26 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive | |
| P478 | volume | 449 |
| Q90620655 | A Binary Arginine Methylation Switch on Histone H3 Arginine 2 Regulates Its Interaction with WDR5 |
| Q36703511 | A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases |
| Q38756663 | A Structural Perspective on Readout of Epigenetic Histone and DNA Methylation Marks |
| Q38857167 | A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression |
| Q39702828 | A chloroacetamidine-based inactivator of protein arginine methyltransferase 1: design, synthesis, and in vitro and in vivo evaluation |
| Q33351290 | A comprehensive library of histone mutants identifies nucleosomal residues required for H3K4 methylation |
| Q33983567 | A gain-of-function mouse model identifies PRMT6 as a NF-κB coactivator |
| Q46762026 | A kinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism |
| Q36386994 | A method for large-scale identification of protein arginine methylation |
| Q36418916 | A novel histone H4 arginine 3 methylation-sensitive histone H4 binding activity and transcriptional regulatory function for signal recognition particle subunits SRP68 and SRP72. |
| Q24303673 | A phospho/methyl switch at histone H3 regulates TFIID association with mitotic chromosomes. |
| Q27342739 | A role for Set1/MLL-related components in epigenetic regulation of the Caenorhabditis elegans germ line |
| Q28510048 | Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor |
| Q36730191 | An assessment of molecular pathways of obesity susceptible to nutrient, toxicant and genetically induced epigenetic perturbation |
| Q33382731 | Analysis of Myc-induced histone modifications on target chromatin |
| Q33316263 | Analysis of the substrate specificity of the Dim-5 histone lysine methyltransferase using peptide arrays |
| Q47652238 | Arginine Methyltransferase 1 in the Nucleus Accumbens Regulates Behavioral Effects of Cocaine. |
| Q34694111 | Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation |
| Q37410634 | Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat. |
| Q41231345 | Arginine methylation of hnRNPUL1 regulates interaction with NBS1 and recruitment to sites of DNA damage |
| Q40036063 | Arginine methylation of the histone H3 tail impedes effector binding |
| Q26749499 | Arginine methyltransferases in normal and malignant hematopoiesis |
| Q37962018 | Arginine/lysine-methyl/methyl switches: biochemical role of histone arginine methylation in transcriptional regulation |
| Q42151914 | Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound. |
| Q90202160 | Assaying epigenome functions of PRMTs and their substrates |
| Q50287074 | CARM1, PRMT6 methylate arginine-3 of histone H3 (H3R2) |
| Q43226742 | Cancer epigenetics: new therapies and new challenges. |
| Q34390742 | Cell cycle regulation by the PRMT6 arginine methyltransferase through repression of cyclin-dependent kinase inhibitors |
| Q37832337 | Chatting histone modifications in mammals |
| Q91758830 | Chemical probes for protein arginine methyltransferases |
| Q49565575 | Chromatin dependencies in cancer and inflammation. |
| Q38199995 | Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer. |
| Q38194444 | Chromatin modifiers and the promise of epigenetic therapy in acute leukemia |
| Q47894270 | Clipping of arginine-methylated histone tails by JMJD5 and JMJD7. |
| Q36514119 | Coactivator-associated arginine methyltransferase 1 regulates fetal hematopoiesis and thymocyte development |
| Q33535222 | Combinatorial profiling of chromatin binding modules reveals multisite discrimination |
| Q27681246 | Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription |
| Q34046593 | Conservation and divergence of the histone code in nucleomorphs |
| Q47069385 | Coordinated regulation of active and repressive histone methylations by a dual-specificity histone demethylase ceKDM7A from Caenorhabditis elegans |
| Q38108662 | Cross-talk among epigenetic modifications: lessons from histone arginine methylation |
| Q24336563 | Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells |
| Q27681586 | Crystal Structure of Arginine Methyltransferase 6 from Trypanosoma brucei |
| Q27677465 | Crystal Structure of TDRD3 and Methyl-Arginine Binding Characterization of TDRD3, SMN and SPF30 |
| Q104794067 | DNA methyltransferase inhibitors modulate histone methylation: epigenetic crosstalk between H3K4me3 and DNA methylation during sperm differentiation |
| Q24316055 | Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex |
| Q42383290 | Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6. |
| Q36474444 | Disease-promoting and -protective genomic loci on mouse chromosomes 3 and 19 control the incidence and severity of autoimmune arthritis. |
| Q34958982 | Distinct transcriptional outputs associated with mono- and dimethylated histone H3 arginine 2. |
| Q41811756 | Diverse functions of WD40 repeat proteins in histone recognition |
| Q36574568 | Diversity and Divergence of Dinoflagellate Histone Proteins |
| Q42286129 | Dynamic acetylation of lysine-4-trimethylated histone H3 and H3 variant biology in a simple multicellular eukaryote. |
| Q37829706 | Dynamic interplay between histone H3 modifications and protein interpreters: emerging evidence for a "histone language". |
| Q34857637 | Dynamic protein methylation in chromatin biology |
| Q38975402 | Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies? |
| Q38092575 | Emerging roles for chromatin as a signal integration and storage platform |
| Q38845518 | Epigenetic Changes in Diabetes and Cardiovascular Risk. |
| Q38107626 | Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation |
| Q51777320 | Epigenetic dysregulation of leukaemic HOX code in MLL-rearranged leukaemia mouse model. |
| Q29616621 | Epigenetic protein families: a new frontier for drug discovery |
| Q90185475 | Epigenetic regulation of oligodendrocyte differentiation: From development to demyelinating disorders |
| Q38021232 | Epigenetic regulation of pancreas development and function |
| Q27016161 | Epigenetic virtues of chromodomains |
| Q35726371 | Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update |
| Q30944751 | Epigenome microarray platform for proteome-wide dissection of chromatin-signaling networks |
| Q29617086 | Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease |
| Q27680503 | Evolutionary Adaptation of the Fly Pygo PHD Finger toward Recognizing Histone H3 Tail Methylated at Arginine 2 |
| Q35690493 | Expression of the epigenetic factor BORIS (CTCFL) in the human genome |
| Q39568693 | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation |
| Q42125382 | Functional interplay between protein arginine methyltransferases in Trypanosoma brucei |
| Q33611702 | Genome-wide views of chromatin structure |
| Q21263183 | Genomic structure and expression of Jmjd6 and evolutionary analysis in the context of related JmjC domain containing proteins |
| Q33761232 | Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition. |
| Q34059326 | Global relevance of Aire binding to hypomethylated lysine-4 of histone-3. |
| Q37961731 | Grasping trimethylation of histone H3 at lysine 4. |
| Q36021719 | H2B monoubiquitylation is a 5'-enriched active transcription mark and correlates with exon-intron structure in human cells |
| Q24319807 | H3R42me2a is a histone modification with positive transcriptional effects |
| Q33722642 | H4R3 methylation facilitates beta-globin transcription by regulating histone acetyltransferase binding and H3 acetylation |
| Q35620862 | Handpicking epigenetic marks with PHD fingers. |
| Q46913032 | Histone H3 Arg2 methylation provides alternative directions for COMPASS. |
| Q64905437 | Histone H3 Mutations: An Updated View of Their Role in Chromatin Deregulation and Cancer. |
| Q37469434 | Histone H3K27 trimethylation inhibits H3 binding and function of SET1-like H3K4 methyltransferase complexes |
| Q35889368 | Histone H3R17me2a mark recruits human RNA polymerase-associated factor 1 complex to activate transcription |
| Q36039453 | Histone H3R2 symmetric dimethylation and histone H3K4 trimethylation are tightly correlated in eukaryotic genomes. |
| Q38796064 | Histone Modifications and Cancer |
| Q58830255 | Histone Recognition by WD40 Proteins |
| Q37809211 | Histone arginine methylation |
| Q37213725 | Histone arginine methylation in cocaine action in the nucleus accumbens |
| Q32884565 | Histone arginine methylation keeps RUNX1 target genes in an intermediate state |
| Q33694050 | Histone arginine methylations: their roles in chromatin dynamics and transcriptional regulation |
| Q36421138 | Histone demethylases and cancer |
| Q37961859 | Histone methylation in myelodysplastic syndromes |
| Q28263573 | Histone methylation: a dynamic mark in health, disease and inheritance |
| Q37780469 | Histone methyltransferases: regulation of transcription and contribution to human disease |
| Q37705706 | Histone modifications as regulators of life and death in Saccharomyces cerevisiae |
| Q38071556 | Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential. |
| Q35229609 | Histones: at the crossroads of peptide and protein chemistry |
| Q35123032 | Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability. |
| Q45966440 | Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond. |
| Q29547350 | How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers |
| Q35868191 | Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming ω-NG-monomethylated arginine residues. |
| Q34551729 | Identification and characterization of new molecular partners for the protein arginine methyltransferase 6 (PRMT6). |
| Q39761332 | Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17. |
| Q34456824 | Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1. |
| Q26782046 | Impact of Chromatin on HIV Replication |
| Q37655842 | In situ histone landscape of nephrogenesis |
| Q33774888 | Influence of combinatorial histone modifications on antibody and effector protein recognition |
| Q92423959 | Inhibition of Protein arginine methyltransferase 6 reduces reactive oxygen species production and attenuates aminoglycoside- and cisplatin-induced hair cell death |
| Q38740496 | Inhibitors of Protein Methyltransferases and Demethylases. |
| Q42182620 | Interaction of SET domains with histones and nucleic acid structures in active chromatin. |
| Q37266141 | Is there a code embedded in proteins that is based on post-translational modifications? |
| Q37703058 | Jmjd6, a JmjC Dioxygenase with Many Interaction Partners and Pleiotropic Functions |
| Q34336457 | Keeping it in the family: diverse histone recognition by conserved structural folds |
| Q39630055 | Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. |
| Q37319902 | Lysine methylation of nuclear co-repressor receptor interacting protein 140. |
| Q58381515 | Methylarginine Recognition by Tudor Domains |
| Q38275332 | Methylation of H2AR29 is a novel repressive PRMT6 target |
| Q52369540 | Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin. |
| Q27650200 | Molecular Basis of Histone H3K4me3 Recognition by ING4 |
| Q36824900 | Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation |
| Q49550075 | Moonlighting with WDR5: A Cellular Multitasker. |
| Q40352908 | Myomaker, Regulated by MYOD, MYOG and miR-140-3p, Promotes Chicken Myoblast Fusion |
| Q27930575 | N-alpha-terminal acetylation of histone H4 regulates arginine methylation and ribosomal DNA silencing |
| Q27027360 | On WD40 proteins: propelling our knowledge of transcriptional control? |
| Q38102573 | On your histone mark, SET, methylate! |
| Q39135199 | Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6. |
| Q38990455 | PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation |
| Q33819263 | PHD fingers: epigenetic effectors and potential drug targets |
| Q92718017 | PRDM15 loss of function links NOTCH and WNT/PCP signaling to patterning defects in holoprosencephaly |
| Q58090240 | PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma |
| Q28487723 | PRMT4 is a novel coactivator of c-Myb-dependent transcription in haematopoietic cell lines |
| Q89561628 | PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2 |
| Q38260494 | PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents |
| Q89665920 | PRMT6 mediates inflammation via activation of the NF-κB/p65 pathway on a cigarette smoke extract-induced murine emphysema model |
| Q39557781 | Pancreatic β cell identity is maintained by DNA methylation-mediated repression of Arx. |
| Q38232008 | Posttranslational modifications of human histone H3: an update |
| Q47909307 | Prefrontal cortex expression of chromatin modifier genes in male WSP and WSR mice changes across ethanol dependence, withdrawal, and abstinence |
| Q34096366 | Principles and challenges of genomewide DNA methylation analysis |
| Q42002770 | Profiling substrates of protein arginine N-methyltransferase 3 with S-adenosyl-L-methionine analogues |
| Q38529273 | Progress and challenges in predicting protein methylation sites. |
| Q24314981 | Promiscuous modification of the nuclear poly(A)-binding protein by multiple protein-arginine methyltransferases does not affect the aggregation behavior |
| Q40407708 | Protein Arginine Methyltransferase 6 (Prmt6) Is Essential for Early Zebrafish Development through the Direct Suppression of gadd45αa Stress Sensor Gene |
| Q36404254 | Protein Arginine Methyltransferase 6 Involved in Germ Cell Viability during Spermatogenesis and Down-Regulated by the Androgen Receptor |
| Q38064312 | Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders. |
| Q38055223 | Protein arginine methylation in Saccharomyces cerevisiae. |
| Q37209124 | Protein arginine methylation in health and disease |
| Q29617309 | Protein arginine methylation in mammals: who, what, and why |
| Q38168045 | Protein arginine methylation of non-histone proteins and its role in diseases |
| Q42696672 | Protein arginine methyltransferase 6 controls erythroid gene expression and differentiation of human CD34+ progenitor cells |
| Q47108247 | Protein arginine methyltransferase 6 regulates embryonic stem cell identity |
| Q33783165 | Protein arginine methyltransferase 6 regulates multiple aspects of gene expression |
| Q28270318 | Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase δ catalytic subunit gene, POLD1 |
| Q38067063 | Protein arginine methyltransferases and cancer |
| Q37726342 | Protein arginine methyltransferases: nuclear receptor coregulators and beyond |
| Q37227192 | Protein lysine methyltransferase G9a acts on non-histone targets |
| Q28507710 | Pwp1 is required for the differentiation potential of mouse embryonic stem cells through regulating Stat3 signaling |
| Q33854968 | Quantitative mass spectrometry of histones H3.2 and H3.3 in Suz12-deficient mouse embryonic stem cells reveals distinct, dynamic post-translational modifications at Lys-27 and Lys-36 |
| Q30375585 | Quantitative proteomic analysis of histone modifications |
| Q41015953 | RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation |
| Q30359633 | Readers of histone methylarginine marks. |
| Q88749962 | Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy |
| Q34406803 | Recruitment of Rpd3 to the telomere depends on the protein arginine methyltransferase Hmt1. |
| Q37338965 | Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription |
| Q38895216 | Rewiring the solid tumor epigenome for cancer therapy |
| Q91565531 | Roles and regulation of histone methylation in animal development |
| Q37615671 | SET for life: biochemical activities and biological functions of SET domain-containing proteins |
| Q37452562 | Set2-dependent K36 methylation is regulated by novel intratail interactions within H3 |
| Q37056442 | Small Molecule Inhibitors of Protein Arginine Methyltransferases. |
| Q41848329 | Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5 |
| Q35666409 | Status of epigenetic chromatin modification enzymes and esophageal squamous cell carcinoma risk in northeast Indian population |
| Q27675100 | Structural basis for histone H3 Lys 27 demethylation by UTX/KDM6A |
| Q34170833 | Structural basis for phosphorylation and lysine acetylation cross-talk in a kinase motif associated with myocardial ischemia and cardioprotection |
| Q24336418 | Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain |
| Q24324784 | Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks |
| Q41633725 | Structural basis of arginine asymmetrical dimethylation by PRMT6. |
| Q24311521 | Structure and site-specific recognition of histone H3 by the PHD finger of human autoimmune regulator |
| Q34126327 | Substitutions in the amino-terminal tail of neurospora histone H3 have varied effects on DNA methylation |
| Q27676661 | Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance |
| Q34691695 | Symmetrical modification within a nucleosome is not required globally for histone lysine methylation |
| Q24318709 | TDRD3 is an effector molecule for arginine-methylated histone marks |
| Q33983096 | TbPRMT6 is a type I protein arginine methyltransferase that contributes to cytokinesis in Trypanosoma brucei |
| Q35915446 | The Arginine Methyltransferase PRMT6 Cooperates with Polycomb Proteins in Regulating HOXA Gene Expression |
| Q47138155 | The Arginine Methyltransferase PRMT6 Regulates DNA Methylation and Contributes to Global DNA Hypomethylation in Cancer |
| Q92444398 | The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma |
| Q39105700 | The Histone Modification Code in the Pathogenesis of Autoimmune Diseases |
| Q92205124 | The KRAB-zinc-finger protein ZFP708 mediates epigenetic repression at RMER19B retrotransposons |
| Q37784884 | The Language of Histone Crosstalk |
| Q36609049 | The MUT9p kinase phosphorylates histone H3 threonine 3 and is necessary for heritable epigenetic silencing in Chlamydomonas |
| Q26752985 | The Role of Protein Arginine Methyltransferases in Inflammatory Responses |
| Q39294978 | The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes |
| Q39000118 | The interaction of MYC with the trithorax protein ASH2L promotes gene transcription by regulating H3K27 modification |
| Q37975976 | The methylproteome and the intracellular methylation network. |
| Q59357618 | The methyltransferase PRMT6 attenuates antiviral innate immunity by blocking TBK1-IRF3 signaling |
| Q45847074 | The protective effect of PRMT6 overexpression on cigarette smoke extract-induced murine emphysema model |
| Q37419015 | The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans |
| Q42216735 | The recognition specificity of the CHD1 chromodomain with modified histone H3 peptides |
| Q92215527 | The regulation, functions and clinical relevance of arginine methylation |
| Q34300706 | The role of WDR5 in silencing human fetal globin gene expression |
| Q38071526 | The role of chromatin modifiers in normal and malignant hematopoiesis |
| Q38015703 | The role of epigenetic regulation in stem cell and cancer biology |
| Q27654188 | The solution structure of the first PHD finger of autoimmune regulator in complex with non-modified histone H3 tail reveals the antagonistic role of H3R2 methylation |
| Q39064771 | The story of protein arginine methylation: characterization, regulation, and function |
| Q32884548 | Thrombospondin-1 is a transcriptional repression target of PRMT6. |
| Q34318365 | Trans-tail regulation of MLL4-catalyzed H3K4 methylation by H4R3 symmetric dimethylation is mediated by a tandem PHD of MLL4 |
| Q38043829 | Transcription-associated histone modifications and cryptic transcription |
| Q37863271 | Transcriptional and epigenetic networks in haematological malignancy |
| Q42028475 | Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3 |
| Q34235226 | Trithorax group proteins: switching genes on and keeping them active |
| Q37136730 | Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively. |
| Q55438230 | Uhrf1 regulates active transcriptional marks at bivalent domains in pluripotent stem cells through Setd1a. |
| Q56835552 | Uncovering combinatorial interactions in chromatin |
| Q27934664 | Yeast Hmt1 catalyses asymmetric dimethylation of histone H3 arginine 2 in vitro |
| Q64289924 | ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma |
| Q28508693 | beta-Catenin primes organizer gene expression by recruiting a histone H3 arginine 8 methyltransferase, Prmt2 |
| Q36341584 | p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6 |
Search more.